Clinical Trials Browser

Resectable Pancreatic Cancer × 130-nm albumin-bound paclitaxel × Clear all

NCT03392571 2019-05-07

Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients

Phase 2 Withdrawn

Gastrointestinal

Resectable Pancreatic Cancer